Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Clinical Lung Cancer|April 3, 2017
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung CancerDavid R Spigel, Alexander Luft, Henrik Depenbrock, et al.Clinical Lung Cancer|July 28, 2009
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancerJyoti D Patel, Philip Bonomi, Mark A Socinski, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2013
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancerHak Choy, Lee S Schwartzberg, Shaker R Dakhil, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancerGerold Bepler, K Eric Sommers, Alan Cantor, et al.Clinical Lung Cancer|November 22, 2017
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung CancerTudor Ciuleanu, Mark A Socinski, Coleman Obasaju, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trialMark A Socinski, Robert N Raju, Marcus Neubauer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 17, 2016
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE TrialMartin Reck, Mark A Socinski, Alexander Luft, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancerCynthia X Ma, Suresh Nair, Sachdev Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.Clinical Breast Cancer|July 5, 2011
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancerAdam Brufsky, Karen Hoelzer, Thaddeus Beck, et al.Pageof 3